KZIA - Kazia Therapeutics Ltd ADR - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KZIA is currently covered by 2 analysts with an average price target of $19. This is a potential upside of $6362.31 (48.21%) from yesterday's end of day stock price of $12.82.

Kazia Therapeutics Ltd ADR's activity chart (see below) currently has 5 price targets and 12 ratings on display. The stock rating distribution of KZIA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 19.05% with an average time for these price targets to be met of 103.43 days.

Highest price target for KZIA is $20, Lowest price target is $18, average price target is $19.

Most recent stock forecast was given by from HC WAINWRIGHT on 28-Jan-2026. First documented stock forecast 04-Jan-2021.

Best performing analysts who are covering KZIA - Kazia Therapeutics Ltd ADR:

Naureen Quibria Jason Mccarthy Sean Lee Naz Rahman

Currently out of the existing stock ratings of KZIA, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Jul-2024

$18

$3.78 (26.58%)

$18

6 months 4 days ago
(28-Jan-2026)

0/3 (0%)

$11.44 (174.39%)

Buy Since 02-Oct-2025

$20

$5.78 (40.65%)

$900

9 months 30 days ago
(02-Oct-2025)

0/2 (0%)

$13.69 (216.96%)

Buy Since 14-Oct-2021

$15

$0.78 (5.49%)

1 years 1 months 21 days ago
(11-Jun-2025)

2/3 (66.67%)

$5.46 (57.23%)

362

$45000

$44992.84 (628391.62%)

4 years 9 months 17 days ago
(15-Oct-2021)

0/1 (0%)

$44475 (8471.43%)

Show more analysts

Please expand the browser size to see the chart

What is KZIA (Kazia Therapeutics Ltd ADR) average time for price targets to be met?

On average it took 103.43 days on average for the stock forecasts to be realized with a an average price target met ratio 19.05

Which analyst has the current highest performing score on KZIA (Kazia Therapeutics Ltd ADR) with a proven track record?

NAUREEN QUIBRIA

Which analyst has the most public recommendations on KZIA (Kazia Therapeutics Ltd ADR)?

Naureen Quibria has 3 price targets and 4 ratings on KZIA

Which analyst is the currently most bullish on KZIA (Kazia Therapeutics Ltd ADR)?

Naureen Quibria with highest potential upside - $44992.84

Which analyst is the currently most reserved on KZIA (Kazia Therapeutics Ltd ADR)?

Jason Mccarthy with lowest potential downside - $0.78

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?